Plasma levels of soluble CD14 independently predict mortality in HIV infection.
By Netanya G. Sandler, H. Wand, A. Roque, M. Law, M. Nason, D. Nixon, C. Pedersen, K. Ruxrungtham, S. Lewin, S. Emery and 5 more. Journal of Infectious Diseases, 2011
1,091 citations recorded by the source corpus.
Subfields: Emergency Medicine, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/11a780e27dc54bb15828205106b850203656fbab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Molecular Biology
Citations in the corpus
- Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. (2014, result): “Earlier studies, however, either did not include a comparable uninfected control group but used general population [8, 29–32, 35] or patient registry data for comparison [27, 28, 33, 34, 36], or were not designed a priori to prospectively capture”
- Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging (2018, background): “Markers of monocyte/macrophage activation in the circulation, such as sCD14, sCD163, and tissue factor (TF), have been linked with mortality, atherosclerosis, and other markers of inflammation and coagulation [89-91].”
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “The chronically activated immune system generates excessive proinflammatory cytokines associated with end-organ disease such as atherosclerosis, diabetes, and renal injury.(622,643,644) Even with suppressive ART, T cell activation remains elevated above that seen in HIV-uninfected individuals.”